Regis Healthcare Ltd's stock price surged 6.01% during intraday trading on Thursday, marking a significant upward movement for the healthcare company.
The sharp rise appears to be driven by the company's positive financial outlook, as it expects its FY26 underlying EBITDA to reach approximately A$135 million, which is at the top end of its guidance range.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.